nausea decreases with ongoing usage a steady weight loss occurs in some patients over 2 years (may be related to nausea & CNS-mediated loss of appetite) there is an increased risk of hypoglycemia when exenatide is used with a sulfonylurea The dose of the sulfonylurea may need to be reduced if hypoglycemia occurs when combined with exenatide Most serious : rare & sometimes fatal necrotizing or hemorrhagic pancreatitis When initiating patients on Byetta, watch for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back, which may or may not be accompanied by vomiting)
With medicines, the method of delivery is carefully chosen to ensure that the right amount of medicine is absorbed by the body over an acceptable amount of time
Careful preparation protects peptide effectiveness during clinical research applications
Customer service and support has been absolutely excellent with check ins and prompt responses to questions
Other serious but less common risks include pancreatitis, gallbladder problems, kidney issues, and hypoglycemia when used with certain other diabetes medications
What happens if I miss a starting dose injection
